» Articles » PMID: 28407576

HOTAIR May Regulate Proliferation, Apoptosis, Migration and Invasion of MCF-7 Cells Through Regulating the P53/Akt/JNK Signaling Pathway

Overview
Date 2017 Apr 14
PMID 28407576
Citations 35
Authors
Affiliations
Soon will be listed here.
Abstract

Breast cancer is a common malignancy, and it is the second leading cause of cancer-related death among women worldwide. The pathogenesis of breast cancer is poorly understood, leading to unsatisfactory efficacy of current anti-PC therapies. The aim of this study is to investigate the role of LncRNA HOTAIR in proliferation, apoptosis, migration and invasion of human breast cancer cell line MCF-7. MCF-7 cells were cultured and transfected with HOTAIR siRNA, and the proliferation rate of cells was determined using MTT and colony-forming assay; moreover, the apoptosis as well as cell cycles were determined using annexin V/propidium iodide staining methods and analyzed using flow cytometery; furthermore, cell scratch and transwell assays have been performed to examine the migration and invasion of MCF-7 cells; Next, cells were collected, and RT-qPCR as well as western blotting assay were performed to examine the expression of P53, MDM2, AKT, JNK, MMP-2 and MMP-9. We discovered that knockdown of HOTAIR induced significant decrease in proliferation and increase in apoptosis of MCF-7 cells, and the cell cycles of HOTAIR siRNA transfected cells have been arrested at G1 phase (p<0.01); moreover, knockdown of HOTAIR lead to marked decrease in the migration and invasion ability of MCF-7 cells; finally, knockdown of HOTAIR induced significant decrease in the expression of P53/Akt/JNK (p<0.01), and significant increase in the expression of P53 in MCF-7 cells (p<0.01). In conclusion, our results proved that HOTAIR may regulate proliferation, apoptosis, migration and invasion of MCF-7 cells through regulating the P53/Akt/JNK signaling pathway.

Citing Articles

HOTAIR in cancer: diagnostic, prognostic, and therapeutic perspectives.

Nazari M, Babakhanzadeh E, Mollazadeh A, Ahmadzade M, Mohammadi Soleimani E, Hajimaqsoudi E Cancer Cell Int. 2024; 24(1):415.

PMID: 39702144 PMC: 11660992. DOI: 10.1186/s12935-024-03612-x.


Harnessing the potential of long non-coding RNAs in breast cancer: from etiology to treatment resistance and clinical applications.

Wang Y, Bu N, Luan X, Song Q, Ma B, Hao W Front Oncol. 2024; 14:1337579.

PMID: 38505593 PMC: 10949897. DOI: 10.3389/fonc.2024.1337579.


Long non-coding RNAs in cancer: multifaceted roles and potential targets for immunotherapy.

Kadian L, Verma D, Lohani N, Yadav R, Ranga S, Gulshan G Mol Cell Biochem. 2024; 479(12):3229-3254.

PMID: 38413478 DOI: 10.1007/s11010-024-04933-1.


Proliferation, Migration and Invasion of Breast Cancer Cell Lines Are Inhibited by 1,5-Disubstituted Tetrazol-1,2,3-triazole Hybrids through Interaction with p53.

Moreno-Perea M, Suarez-Castro A, Fraire-Soto I, Sifuentes-Padilla J, Gutierrez-Hernandez R, Reyes-Estrada C Molecules. 2023; 28(22).

PMID: 38005322 PMC: 10673467. DOI: 10.3390/molecules28227600.


Regulatory miRNAs, circRNAs and lncRNAs in cell cycle progression of breast cancer.

Chen H, Xie G, Luo Q, Yang Y, Hu S Funct Integr Genomics. 2023; 23(3):233.

PMID: 37432486 DOI: 10.1007/s10142-023-01130-z.